Sobr Safe, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
SOBR Safe, Inc. announced the successful exercise of outstanding warrants, generating approximately $3.1 million in gross proceeds through the issuance of new warrants.
NASDAQ
SOBR Safe, Inc. is ceasing its alcohol monitoring hardware and software operations to preserve cash for a proposed business combination.
NASDAQ
SOBR Safe, Inc. has received an extension until September 15, 2026, to regain compliance with Nasdaq's minimum bid price requirement.
NASDAQ
SOBR Safe Inc. is implementing a significant restructuring, including an 11-employee reduction (approximately 70% of its workforce), to cut annual operating costs by $1.6 million.
NASDAQ
SOBR Safe, Inc. has announced the postponement of its 2026 Annual Meeting of Stockholders originally scheduled for May 18, 2026.
NASDAQ
SOBR Safe, Inc. announced the date for its 2026 Annual Meeting of Stockholders and key deadlines for stockholder proposals and director nominations.
NASDAQ
SOBR Safe, Inc. received a Nasdaq deficiency letter for failing to meet the minimum $1.00 bid price requirement, complicated by prior reverse stock splits.
NASDAQ
SOBR Safe, Inc. extended the employment agreements for its CEO and CFO through December 31, 2026, and appointed Broadridge Financial as its new transfer agent.
NASDAQ
SOBRsafe completed a $2 million private placement, issuing common stock and various warrants to institutional investors for working capital and general corporate purposes.
NASDAQ
SOBRsafe reported a 136.1% year-over-year revenue increase in Q3 2025, driven by strong sales of its SOBRsure GEN 2 devices and software subscriptions.
NASDAQ
SOBRsafe announced the grant of a European Patent for its SOBRcheck device and reported a 92.3% year-over-year revenue increase for Q2 2025, alongside a reduced net loss.
NASDAQ
SOBRsafe announced that independent testing by KEA Technologies confirmed the strong core sensing capabilities and consistent performance of its SOBRsure GEN 2 device, positioning the company for accelerated market expansion.
NASDAQ
SOBR Safe, Inc. shareholders approved key corporate governance changes, including a staggered board structure and an increase in shares for its equity incentive plan, while also granting the Board discretion to implement a reverse stock split to maintain Nasdaq listing.
NASDAQ
SOBR Safe, Inc. appoints Kris Pederson to its Board of Directors and Dr. Benjamin Sanchez as a Scientific Advisor to enhance governance, strategy, and technology development.
NASDAQ
SOBR Safe, Inc. has announced a 1-for-10 reverse stock split of its common stock, effective April 4, 2025.
NASDAQ
SOBR Safe Inc. stockholders approved the issuance of shares upon warrant exercise and granted the board discretion to implement a reverse stock split at a special meeting held on December 9, 2024.
NASDAQ
SOBR Safe, Inc. has successfully regained compliance with Nasdaq's minimum bid price, public float, and stockholders' equity requirements, allowing its stock to continue trading on the Nasdaq Capital Market.
NASDAQ
SOBR Safe, a provider of transdermal alcohol detection solutions, has successfully priced an $8.2 million private placement with institutional investors to fund general corporate purposes and working capital.
NASDAQ
SOBR Safe, Inc. is facing a potential delisting from the Nasdaq Capital Market due to not meeting the minimum publicly held shares requirement, despite a recent reverse stock split and private placement.
NASDAQ
SOBR Safe, Inc. has announced a 1-for-110 reverse stock split of its common stock, effective October 2, 2024, to increase its share price and regain compliance with Nasdaq's minimum bid price requirement.
NASDAQ
SOBR Safe, Inc. has been granted an extension until October 23, 2024, to regain compliance with Nasdaq's minimum bid price and stockholders' equity requirements.
NASDAQ
SOBR Safe Inc. stockholders approved the issuance of up to 20,638,326 shares of common stock upon conversion of a warrant at a special meeting held on July 22, 2024.
NASDAQ
SOBR Safe, Inc. held its 2024 Annual Stockholder Meeting on June 3, 2024, where all four proposals were approved, including the election of directors and a reverse stock split authorization.
NASDAQ
SOBR Safe, Inc. has entered into an agreement to induce the exercise of existing warrants, resulting in the issuance of new warrants and approximately $2.8 million in gross proceeds.
NASDAQ
SOBR Safe, Inc. has received a delisting notice from Nasdaq after failing to meet minimum share price and stockholders' equity requirements, and intends to appeal the decision.
NASDAQ
SOBR Safe, Inc. has received a notification from Nasdaq for not meeting the minimum stockholders' equity requirement, placing its listing at risk.
NASDAQ
SOBR Safe Inc. has successfully incentivized holders of its senior convertible notes to convert a portion of their debt into equity by reducing the conversion price to $0.62 per share.